🟢 EIQ.AX is trading 28% up today on A$20M Pro Medicus funding and US partnership

EIQ.AX is trading 28% up at A$1.59 after announcing a strategic funding agreement and U.S. commercial partnership with Pro Medicus.

• The deal provides up to A$20 million in secured convertible notes and debt, significantly strengthening the company's capital position and funding runway.
• Pro Medicus will act as a U.S. reseller for Echo IQ’s EchoSolv software, a move expected to accelerate commercialisation and market penetration in the United States.
• The partnership validates Echo IQ's technology through a major industry player, substantially boosting investor confidence in the company's growth trajectory.